Transparency Market Research Transcriptomics Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Published Date 2013-10-10
97 Page Report
Buy Now
Request Sample
Press Release
Global Transcriptomics Technologies Market will Reach US$4.6 billion 2019 Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com
Transcriptomics Technologies Market
REPORT DESCRIPTION
Transcriptomics Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019 U.S.-based intelligence firm, Transparency Market Research (TMR) recently published a report titled, “Transcriptomics Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”. This extensively researched report states, the global transcriptomics technologies market was valued US$1.65 billion in 2012, and is expected to reach a value of US$4.6 billion 2019 growing at a CAGR of 15.9% from 2013 to 2019. This global transcriptomics technologies market research report gives an in-depth insight into gene regulation mechanisms and gene expression in both, normal and diseased cells. The report is also a valuable tool in determining the never-seen-before gene sequences and subsequent drug targets. Transcriptomics is the study of transcriptome, the complete set of RNA transcripts given by a genome under a given circumstance or an individual cell under throughput methods such as microarray analysis. The global transcriptomics technologies market has witnessed an upward trend in the recent past due to the growing need for companion diagnostics and personalized medicine. The transcriptomics technologies industry uses theoretical and empirical understandings from both, biotechnology and pharmaceutical industry to support its medical and healthcare medical research projects. The important factors contributing to the growth of global transcriptomics technologies market are increased spending on research and development on healthcare projects by biotechnology and pharmaceutical companies and technological advancements. Additionally, the ongoing attempts at discovering novel gene sequences and biomarkers will fuel the growth and adoption of transcriptomics technologies across the world. Browse The Market Research Report of Transcriptomics Technologies Market : http://www.transparencymarketresearch.com/transcriptomics-technologiesmarket.html The global transcriptomics technologies market also faces some stifling restraints such as poor quality of bioinformatics tools used in transcriptome analysis, negligible awareness about genomic medicine, and lack of domain expertise. However, expert industry analysts suggest, increasing investments in research by biotechnology and pharmaceutical companies for targeted therapeutics is a lucrative opportunity for the global transcriptomics technologies market. The
Transparency Market Research
2
Transcriptomics Technologies Market
ongoing contract research outsourcing trend will prove to be extremely resourceful for commercialization of global transcriptomics technologies market in the coming years. The global transcriptomics technologies market has been segmented on the basis of technology, application and geography. The technological segmentation is made on the basis of microarrays, polymerase chain reaction (PCR), gene regulation technologies, and next generation sequencing (NGS). The segmentation made on the application includes clinical diagnostics, drug discovery and research, bioinformatics, and comparative transcriptomics studies. In terms of geography, the segmentation is seen through regions such as North America, Europe, Asia Pacific and Rest of the World. Get Free Sample Report : http://www.transparencymarketresearch.com/sample/sample.php? flag=s&rep_id=1659 In the forecasted period, Asia Pacific is expected to see growth in the transcriptomics technologies market at a remarkable pace due to large population base and vendors looking at this region at from a manufacturing point of view. Some of the important players profiled in the global transcriptomics technologies market research report are Affymetrix, Inc., Thermo Fisher Scientific., Agilent Technologies, Inc., F-Hoffmann La Roche Ltd., Illumina, Inc., and Life Technologies Corporation. Browse Press Release of Transcriptomics Technologies Market : http://www.transparencymarketresearch.com/pressrelease/transcriptomicstechnologies-market.htm TABLE OF CONTENT
Chapter 1 Preface 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 1.4 List of Abbreviations
Transparency Market Research
3
Transcriptomics Technologies Market
Chapter 2 Executive Summary
Chapter 3 Market Overview 3.1 Introduction 3.1.1 Market Potential of Transcriptomics Technologies 3.1.2 Future Scenario of Transcriptomics 3.1.3 Market Dynamics 3.2 Market Drivers 3.2.1 Technological Advancements 3.2.2 Rising Preference for Personalized Medicine from both ends (Manufacturers and Consumers) 3.2.3 Increasing Research and Development Investments 3.2.4 Impact Analysis of Market Drivers 3.3 Market Restraints 3.3.1 Lack Of Efficient Data Analysis Tools 3.3.2 Impact Analysis of Market Restraints 3.4 Market Opportunities 3.4.1 Focus on Development of Bioinformatics Tools and Services 3.5 Porter’s Five Forces Analysis: Global Transcriptomics Technologies Market
Transparency Market Research
4
Transcriptomics Technologies Market
3.5.1 Bargaining Power Of Buyers 3.5.2 Bargaining Power Of Suppliers 3.5.3 Threat of Substitutes 3.5.4 Threat of New Entrants 3.5.5 Competitive Rivalry 3.6 Market Attractiveness Analysis: Global Transcritpomics Technologies Market, By Geography
Chapter 4 Global Transcriptomics Technologies Market, By Technology 4.1 Introduction 4.2 Microarrays 4.2.1 Global Microarrays Market, Size and Forecast, 2011 - 2019 (USD Million) 4.2.2 Polymerase Chain Reaction (PCR) 4.2.2.1 Global PCR Market, Size and Forecast, 2011 - 2019 (USD Million) 4.2.3 Gene Regulation Technologies (RNA Interference Technology) 4.2.3.1 Global Gene Regulation Technologies Market, Size and Forecast, 2011 - 2019 (USD Million) 4.2.4 Next Generation Sequencing (NGS) 4.2.4.1 Global Next Generation Sequencing Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)
Transparency Market Research
5
Transcriptomics Technologies Market
Chapter 5 Global Transcriptomics Technologies Market, By Application 5.1 Overview 5.2 Clinical Diagnostics 5.2.1 Global Clinical Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million) 5.3 Drug Discovery And Research 5.3.1 Global Drug Discovery and Research Market, Size and Forecast, 2011 - 2019 (USD Million) 5.4 Bioinformatics 5.4.1 Global Bioinformatics Market, Size and Forecast, 2011 - 2019 (USD Million) 5.5 Comparative Transcriptome Studies 5.5.1 Global Comparative Transcriptome Studies Market, Size and Forecast, 2011 - 2019 (USD Million)
Chapter 6 Global Transcriptomics Technologies Market, By Geography 6.1 Overview 6.1.1 Global Transcriptomics Technologies Market, By Geography, Size and Forecast, 2011 – 2019 (USD Million) 6.1.2 Comparative Analysis: Global Transcriptomics Technologies Market, By Geography, 2012 & 2019 (Value %) 6.2 North America 6.2.1 North America Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)
Transparency Market Research
6
Transcriptomics Technologies Market
6.3 Europe 6.3.1 Europe Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million) 6.4 Asia-Pacific 6.4.1 Asia-Pacific Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million) 6.5 Rest of the World (Row) 6.5.1 Row Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)
Chapter 7 Competitive Landscape 7.1 Market Share By Key Players: Global Transcriptomics Technologies Market, 2012 (%)
Chapter 8 Recommendations 8.1 Collaboration with Academic and Research Institutes 8.2 Focus on Imparting Education about Genomic Medicine
Chapter 9 Company Profiles 9.1 Affymetrix, Inc. 9.1.1 Company Overview 9.1.2 Financial Overview
Transparency Market Research
7
Transcriptomics Technologies Market
9.1.3 Product Portfolio 9.1.4 Business Strategies 9.1.5 Recent Developments 9.2 Agilent Technologies, Inc. 9.2.1 Company Overview 9.2.2 Financial Overview 9.2.3 Product Portfolio 9.2.4 Business Strategies 9.2.5 Recent Developments 9.3 Bio-Rad Laboratories, Inc. 9.3.1 Business Overview 9.3.2 Financial Overview 9.3.3 Product Portfolio 9.3.4 Business Strategies 9.3.5 Recent Developments 9.4 Danaher Corporation 9.4.1 Business Overview 9.4.2 Financial Overview 9.4.3 Product Portfolio 9.4.4 Business Strategies
Transparency Market Research
8
Transcriptomics Technologies Market
9.4.5 Recent Developments 9.5 F. Hoffmann-La Roche Ltd. 9.5.1 Company Overview 9.5.2 Financial Overview 9.5.3 Product Portfolio 9.5.4 Business Strategies 9.5.5 Recent Developments 9.6 Illumina, Inc. 9.6.1 Company Overview 9.6.2 Financial Overview 9.6.3 Product Portfolio 9.6.4 Business Strategies 9.6.5 Recent Developments 9.7 Life Technologies Corporation 9.7.1 Company Overview 9.7.2 Financial Overview 9.7.3 Product Portfolio 9.7.4 Business Strategies 9.7.5 Recent Developments 9.8 LC Sciences, LLC
Transparency Market Research
9
Transcriptomics Technologies Market
9.8.1 Company Overview 9.8.2 Financial Overview 9.8.3 Product Portfolio 9.8.4 Business Strategies 9.8.5 Recent Developments 9.9 Qiagen N.V. 9.9.1 Company Overview 9.9.2 Financial Overview 9.9.3 Product Portfolio 9.9.4 Business Strategies 9.9.5 Recent Developments 9.10 Sigma-Aldrich Corporation 9.10.1 Company Overview 9.10.2 Financial Overview 9.10.3 Product Portfolio 9.10.4 Business Strategies 9.10.5 Recent Developments 9.11 Thermo Fisher Scientific 9.11.1 Company Overview 9.11.2 Financial Overview
Transparency Market Research
10
Transcriptomics Technologies Market
9.11.3 Product Portfolio 9.11.4 Business Strategies 9.11.5 Recent Developments List of Figures
FIG. 1 Central Dogma : Transcriptomics Technologies Market FIG. 2 Transcriptomics Technologies: Market Segmentation FIG. 3 Global Transcriptomics Technologies Market, By Technology, 2012 (USD Million) FIG. 4 Porter’s Five Forces Analysis: Global Transcriptomics Technologies Market FIG. 5 Market Attractiveness Analysis: Global Transcriptomics Technologies Market, By Geography FIG. 6 Global Microarrays Market, Size and Forecast, 2011 - 2019 (USD Million) FIG. 7 Global PCR Market, Size and Forecast, 2011 - 2019 (USD Million) FIG. 8 Global Gene Regulation Market, Size and Forecast, 2011 - 2019 (USD Million) FIG. 9 Global Next Generation Sequencing Technologies Market, Size and Forecast, 2011 - 2019 (USD Million) FIG. 10 Global Clinical Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million) FIG. 11 Global Drug Discovery Market, Size and Forecast, 2011 - 2019 (USD Million) FIG. 12 Global Bioinformatics Market, Size and Forecast, 2011 - 2019 (USD Million) FIG. 13 Global Comparative Transcriptome Studies Market, Size and Forecast, 2011 - 2019 (USD Million)
Transparency Market Research
11
Transcriptomics Technologies Market
FIG. 14 Comparative Analysis: Global Transcriptomics Technologies Market, By Geography, 2012 & 2019 (Value %) FIG. 15 North America Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million) FIG. 16 Europe Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million) FIG. 17 Asia-Pacific Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million) FIG. 18 Row Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million) FIG. 19 Market Share Analysis: Global Transcriptomics Technologies Market, 2012 (%) FIG. 20 Affymetrix, Inc., Annual Revenue: 2010 – 2012 (USD Million) FIG. 21 Agilent Technologies, Inc., Annual Revenue: 2010 – 2012 (USD Million) FIG. 22 Bio-Rad Laboratories, Inc., Annual Revenue: 2010 – 2012 (USD Million) FIG. 23 Danaher Corporation, Annual Revenue: 2010 – 2012 (USD Million) FIG. 24 F. Hoffmann-La Roche Ltd., Annual Revenue: 2010 – 2012 (USD Million) (1 CHF = 1.09 USD) FIG. 25 Illumina, Inc., Annual Revenue: 2010 – 2012 (USD Million) FIG. 26 Life Technologies Corporation, Annual Revenue: 2010 – 2012 (USD Million) FIG. 27 Qiagen N.V., Annual Revenue: 2010 – 2012 (USD Million) FIG. 28 Sigma Aldrich Corporation, Annual Revenue: 2010 – 2012 (USD Million) FIG. 29 Thermo Fisher Scientific, Annual Revenue: 2010 – 2012 (USD Million) List of Tables
Transparency Market Research
12
Transcriptomics Technologies Market
TABLE 1 List of Abbreviations TABLE 2 Market Snapshot: Global Transcriptomics Technologies Market TABLE 3 Impact Analysis of Market Drivers TABLE 4 Impact Analysis of Market Restraints TABLE 5 Global Transcriptomics Technologies Market, By Technology, Size and Forecast, 20112019 (USD Million) TABLE 6 Global Transcriptomics Technologies Market, By Application, Size and Forecast, 20112019 (USD Million) TABLE 7 Global Transcriptomics Technologies Market, By Geography, Size and Forecast,
2011
– 2019(USD Million)
Browse All Biotechnology Market Research Reports @ http://www.transparencymarketresearch.com/biotechnology-market-reports-18.html About Us
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Transparency Market Research
13
Transcriptomics Technologies Market
Contact Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/
Transparency Market Research
14